On Tuesday, Altimmune Inc (NASDAQ: ALT) opened lower -1.63% from the last session, before settling in for the closing price of $8.57. Price fluctuations for ALT have ranged from $2.76 to $14.84 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 115.21% annually for the last half of the decade. Company’s average yearly earnings per share was noted 16.83% at the time writing. With a float of $70.53 million, this company’s outstanding shares have now reached $70.68 million.
In an organization with 59 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -3857.69%, operating margin of -191365.38%, and the pretax margin is -199076.92%.
Altimmune Inc (ALT) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Altimmune Inc is 0.83%, while institutional ownership is 56.16%. The most recent insider transaction that took place on Aug 19 ’24, was worth 110,547. In this transaction Director of this company sold 16,011 shares at a rate of $6.90, taking the stock ownership to the 41,958 shares.
Altimmune Inc (ALT) Latest Financial update
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.33 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.38) by 0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.38 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 16.83% per share during the next fiscal year.
Altimmune Inc (NASDAQ: ALT) Trading Performance Indicators
Check out the current performance indicators for Altimmune Inc (ALT). In the past quarter, the stock posted a quick ratio of 16.87. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11991.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.55, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.15 in one year’s time.
Technical Analysis of Altimmune Inc (ALT)
Let’s dig in a bit further. During the last 5-days, its volume was 3.14 million. That was inferior than the volume of 3.85 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 44.54%. Additionally, its Average True Range was 0.78.
During the past 100 days, Altimmune Inc’s (ALT) raw stochastic average was set at 53.61%, which indicates a significant increase from 35.61% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 138.59% in the past 14 days, which was higher than the 84.24% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.14, while its 200-day Moving Average is $7.56. However, in the short run, Altimmune Inc’s stock first resistance to watch stands at $8.98. Second resistance stands at $9.52. The third major resistance level sits at $9.82. If the price goes on to break the first support level at $8.14, it is likely to go to the next support level at $7.84. The third support level lies at $7.30 if the price breaches the second support level.
Altimmune Inc (NASDAQ: ALT) Key Stats
There are currently 71,125K shares outstanding in the company with a market cap of 599.58 million. Presently, the company’s annual sales total 430 K according to its annual income of -88,450 K. Last quarter, the company’s sales amounted to 10 K and its income totaled -22,850 K.
